Search results
What Are the Most Effective Psoriasis Therapy Options?
Verywell Health via Yahoo News· 1 day agoWith many treatment options for psoriasis, how do you know which ones are right for you? Here are...
Does the Anti-Inflammatory Diet for Psoriasis Help Manage Symptoms?
Verywell Health via Yahoo News· 3 days agoInflammation is one of the underlying causes of psoriasis, and research shows that an...
FDA Approval of Alvotech/Teva Ustekinumab Biosimilar | JD Supra
JD Supra· 2 days agoOn April 16, Alvotech and Teva announced the FDA approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Johnson and Johnson’s STELERA® (ustekinumab). The product was approved as a subcutaneous ...
VTYX IMPORTANT DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Ventyx Biosciences, Inc....
WPRI Providence· 4 days agoWHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Ventyx Biosciences, Inc. (NASDAQ: VTYX): (i) pursuant and/or traceable to the offering documents ...
VENTYX BIOSCIENCES, INC. (NASDAQ: VTYX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Ventyx...
Morningstar· 3 days agoDo you, or did you, own shares of Ventyx Biosciences, Inc. (NASDAQ: VTYX)? Did you purchase your shares pursuant and/or traceable to the Company’s October 21, 2021 IPO, or between October 21 ...
Op-ed: Here are 6 health-care stocks to watch now, amid a bumpy recovery
CNBC· 17 hours agoHealth care, long an ailing stock market sector, has recovered over the past six months, with...
Novartis (NVS) Q1 Earnings, Sales Beat, Guidance Raised
Zacks via Yahoo Finance· 2 days agoCosentyx’s sales (psoriasis, spondylitis, arthritis) increased 25% to $1.3 billion, beating the...
UCB SA (OTCMKTS:UCBJY) Declares Dividend of $0.46
ETF DAILY NEWS· 4 days agoUCB SA (OTCMKTS:UCBJY – Get Free Report) declared a dividend on Friday, April 19th, investing.com reports. Stockholders of record on Monday, April 29th will be given a dividend of 0.4574 per ...
YHB Investment Advisors Inc. Trims Stake in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 6 days agoYHB Investment Advisors Inc. reduced its position in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 6.7% during the 4th quarter, according to its most recent 13F filing with the Securities ...
TD Cowen Lowers Amgen (NASDAQ:AMGN) Price Target to $360.00
ETF DAILY NEWS· 6 days agoAmgen (NASDAQ:AMGN – Get Free Report) had its price target dropped by TD Cowen from $370.00 to $360.00 in a research note issued on Wednesday, Benzinga reports. The brokerage currently has a ...
